1 / 70

Prepare par: Dr Mich le van Vugt , Internist-inf dis, PharmAccess

Objectifs de l'atelier. 1. Principes de la pharmacor

derron
Télécharger la présentation

Prepare par: Dr Mich le van Vugt , Internist-inf dis, PharmAccess

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Prepare par: Dr Michle van Vugt , Internist-inf dis, PharmAccess/CPCD/AMC, Les Pays bas Dr Ponsiano Kaleebu, virologist , MRC, Uganda Workshop Phycisians Les donnes de base de la rsistance du VIH

    2. Objectifs de latelier 1. Principes de la pharmacorsistance 2. Transmission du VIH pharmacorsistant 3. Code gntique du VIH

    3. Questions et rponses

    4. Avec du monotherapie, le VIH se peut developer plus vite le rsistance Pourquoi ?

    5. Htrognit virale Production de 1-10 billions de particules VIH par jour 2 copies de RNA VIH par particule de virus Pas de corrections dpreuves => 1 mutation par nouvelle copie RNA VIH 2-20 billions de mutations par jour! Recombinaison entre diffrents variants

    6. Pour cette raison Population de virus avec diversit gntique extrmement leve: Population de virus trs large Toute mutation pensable peut tre prsente: Quasispecies

More Related